- APY0201
-
- $109.00 / 5mg
-
2026-03-13
- CAS:1232221-74-7
- Min. Order:
- Purity: 99.74%
- Supply Ability: 10g
|
| | (E)-4-(5-(2-(3-methylbenzylidene)hydrazinyl)-2-(pyridin-4-yl)pyrazolo[1,5-a]pyrimidin-7-yl)morpholine Basic information |
| Product Name: | (E)-4-(5-(2-(3-methylbenzylidene)hydrazinyl)-2-(pyridin-4-yl)pyrazolo[1,5-a]pyrimidin-7-yl)morpholine | | Synonyms: | (E)-4-(5-(2-(3-methylbenzylidene)hydrazinyl)-2-(pyridin-4-yl)pyrazolo[1,5-a]pyrimidin-7-yl)morpholine;APY0201;N-(3-Methylbenzylidene)-N'-[7-(morpholin-4-yl)-2-(pyridin-4-yl)pyrazolo[1,5-a]pyrimidin-5-yl]hydrazine;N-(3-methylbenzylidene)-N'-(7-morpholin-2-pyridin-4-yl-pyrazolo[1,5-a]pyrimidin-5-yl)hydrazine;APY 0201 ;APY-0201 ;APY0201;APY0201, >98%;4-{5-[(E)-2-[(3-methylphenyl)methylidene]hydrazin-1-yl]-2-(pyridin-4-yl)pyrazolo[1,5-a]pyrimidin-7-yl}morpholine;Benzaldehyde, 3-methyl-, 2-[7-(4-morpholinyl)-2-(4-pyridinyl)pyrazolo[1,5-a]pyrimidin-5-yl]hydrazone | | CAS: | 1232221-74-7 | | MF: | C23H23N7O | | MW: | 413.48 | | EINECS: | | | Product Categories: | Inhibitors | | Mol File: | 1232221-74-7.mol | ![(E)-4-(5-(2-(3-methylbenzylidene)hydrazinyl)-2-(pyridin-4-yl)pyrazolo[1,5-a]pyrimidin-7-yl)morpholine Structure](CAS/20180703/GIF/1232221-74-7.gif) |
| | (E)-4-(5-(2-(3-methylbenzylidene)hydrazinyl)-2-(pyridin-4-yl)pyrazolo[1,5-a]pyrimidin-7-yl)morpholine Chemical Properties |
| density | 1.33±0.1 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMSO:20.0(Max Conc. mg/mL);48.37(Max Conc. mM) DMSO:PBS (pH 7.2) (1:2):0.33(Max Conc. mg/mL);0.8(Max Conc. mM) DMF:3.0(Max Conc. mg/mL);7.26(Max Conc. mM) | | form | A crystalline solid | | pka | 17.36±0.70(Predicted) | | color | Light yellow to yellow |
| | (E)-4-(5-(2-(3-methylbenzylidene)hydrazinyl)-2-(pyridin-4-yl)pyrazolo[1,5-a]pyrimidin-7-yl)morpholine Usage And Synthesis |
| Uses | APY0201 is a potent PIKfyve inhibitor, which inhibits the conversion of PtdIns3P to PtdIns(3,5)P2 in the presence of in the presence of [33P]ATP with an IC50 of 5.2 nM. APY0201 also inhibits IL-12/IL-23 production. | | in vivo | Oral APY0201 at a 30 mg/kg dose shows significant reduction of IL-12p70 production (78% inhibition relative to that of the vehicle control), which implys that the inhibitory potential of APY0201 against IL-12 is confirmed in the animal experiment[1]. | | IC 50 | PIKfyve: 5.2 nM (IC50); IL-12; IL-23 | | References | [1] Hayakawa N, et al. Structure-activity relationship study, target identification, and pharmacological characterization of a small molecular IL-12/23 inhibitor, APY0201. Bioorg Med Chem. 2014 Jun 1;22(11):3021-9. DOI:10.1016/j.bmc.2014.03.036 |
| | (E)-4-(5-(2-(3-methylbenzylidene)hydrazinyl)-2-(pyridin-4-yl)pyrazolo[1,5-a]pyrimidin-7-yl)morpholine Preparation Products And Raw materials |
|